Ahead Of HPV Immunisation, Lancet Reports India's Highest Cervical Cancer Cases In Asia

According to the most recent Lancet report on cases of cervical cancer, India has the highest disease burden in Asia, followed by China.

Varun Verma
Written by: Varun VermaUpdated at: Dec 15, 2022 13:26 IST
Ahead Of HPV Immunisation, Lancet Reports India's Highest Cervical Cancer Cases In Asia

According to the most recent Lancet report on cases of cervical cancer, India has the highest disease burden in Asia, followed by China. According to the study, India accounted for 23% of all cervical cancer fatalities, while China accounted for 17%. In 2020, there were approximately 6,04,127 new cases of cervical cancer and 3,41,831 fatalities worldwide. According to the study data, India reported around 21% of all cervical cases.

Earlier this week, Dr NK Arora, National Technical Advisory Group on Immunisation Chief, spoke to ANI that as a part of a nationwide programme, India would soon deliver the HPV vaccine to girls of nine to 14 years of age.

About the Study

This recent report is based on the 2020 estimates of The Global Cancer Observatory (GLOBOCAN), which includes geographical, socioeconomic development, and temporal factors.

Also Read5 Facts About Cervical Cancer That Indian Women Need to Know

According to the study, there is a clear and substantial socioeconomic gradient between cervical cancer cases and mortality rates and mean national HDI values, with lower rates reported as HDI grew.

The steep decrease in incidence that was observed in some countries, such as India, Brazil, Thailand, and Poland, could be attributed to various factors. This included declines in fertility rates and lower parity, which are declining across successive generations of women, or improvements in screening programme coverage and access to treatment services, particularly among the urban population of the registry catchment areas, according to the study.

Cervical Cancer In India

The study noted that Asia accounted for more than 58% of all cervical cancer cases expected in Asia, followed by Africa (20%), Europe (10%), and Latin America (10%). The case fatality rate is also high in Asia at 58%, followed by Africa at 22%, and Latin America at 9%. Around 39% of all cases occurred in China and India (respectively at 18 and 21%), with 40% of total cervical cancer fatalities occurred (17% in China; 23% in India).

Also ReadCervical Cancer Prevention: The Importance Of Pap Smear Tests For Women

The study said that in 173 of 185 countries, the age-standardised incidence of cervical cancer in 2020 was greater than the threshold set by World Health Organisation’s Cervical Cancer Elimination Initiative.

Earlier this week, Dr NK Arora, National Technical Advisory Group on Immunisation Chief, informed ANI that as a part of a nationwide programme, India would soon deliver the HPV vaccine to girls of nine to 14 years of age. He further stated that screening for cervical illness beyond 35 is critical and that early detection is manageable at the primary health centre (PHC).

Image Credit: freepik

Disclaimer